2Bernard GR,Artigas A,Brigham KL,et al.The American-Europe consensus conference on ARDS:definitions,mechanisms,relevant outcomes,and clinical trial coordination[J].Am J Respir Crit Care Med,1994,149(3pt1):818-824.
3Atabai K,Matthay MA.The pulmonary physician in critical care.5:Acute lung injury and the acute respiratory distress syndrome:definitions and epidemiology[J].Thorax,2002,57(5):452-458.
4Verbrugge SJ,Lachmann B,Kesecioglu J.Lung protective ventilatory strategies in acute lung injury and acute respiratory distress syndrome:from experimental findings to clinical application[J].Clin Physiol Funct Imaging,2007,27(2):67-90.
5Haitsma JJ,Lachmann B.Lung protective ventilation in ARDS:the open lung maneuver[J].Minerva Anestesiol,2006,72(3):117-132.
6Thompson BT.Glucocorticoid and acute lung injury[J].Crit Care Med,2003,31(4 Suppl):S253-S257.
7Davidson WJ,Dorscheid D,Spragg R,et al.Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome:results of a meta-analysis[J].Crit Care,2006,10(2):R41.
9van Kaam AH,Haitsma JJ,Dik WA,et al.Response to exogenous surfactant is different during open lung and conventional ventilation[J].Crit Care Med,2004,32(3):774-780.
10Camamo JM,McCoy RH,Erstad BL.Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome[J].Pharmacotherapy,2005,25(2):184-190.
